Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLudwig Boltzmann Institute for Lung Health

About this trial

The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death.

There are no additional interventions regarding this registry.

Eligibility criteria

Qualifiers

diagnosis of interstitial lung disease

written informed consent

Disqualifiers

to not comprehend and rightfully judge participation

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed